Abionyx Pharma annual operating expenses
2019
2020
2021
2022
2023
2024
2025
Abionyx Pharma Operating Expenses Growth & History (ABNX)
Abionyx Pharma's operating expenses was €6.1M for fiscal 2025.
View full Abionyx Pharma company overviewAbionyx Pharma annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €6.1M | €763,000 | +14.37% |
| 2024 | 2024-12-31 | €5.3M | €1.3M | +31.74% |
| 2023 | 2023-12-31 | €4.0M | −€715,000 | −15.07% |
| 2022 | 2022-12-31 | €4.7M | −€1.5M | −23.60% |
| 2021 | 2021-12-31 | €6.2M | €3.2M | +109.27% |
| 2020 | 2020-12-31 | €3.0M | €443,000 | +17.54% |
| 2019 | 2019-12-31 | €2.5M | — | — |
Abionyx Pharma operating expenses trends
Over the last five fiscal years, Abionyx Pharma's operating expenses increased from €3.0M to €6.1M, a change of €3.1M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
reported and calculated operating expenses
TickerStat uses operating expenses reported in company official filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Abionyx Pharma source filings ↗